Fang, X., et al. “Dose-Response Relationship Between Dietary Magnesium Intake and Cardiovascular Mortality: A Systemic Review and Dose-Based Meta-Regression Analysis of Prospective Studies”. Journal of Trace Elements in Medicine and Biology 38 (2016): 64–73.

Glintborg, D. “Increased Thrombin Generation in Women with Polycystic Ovary Syndrome: A Pilot Study on the Effect of Metformin and Oral Contraceptives”. Metabolism 64, no. 10 (2015): 1272–78.

Greenlund, K. J., et al. “Associations of Oral Contraceptive Use with Serum Lipids and Lipoproteins in Young Women: The Bogalusa Heart Study”. Annals of Epidemiology 7, no. 8 (1997): 561–67.

Haarala, A., et al. “Use of Combined Oral Contraceptives Alters Metabolic Determinants and Genetic Regulation of C-Reactive Protein. The Cardiovascular Risk in Young Finns Study”. Scandinavian Journal of Clinical and Laboratory Investigation 69, no. 2 (2009): 168–74.

Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.

Houston, M. “The Role of Magnesium in Hypertension and Cardiovascular Disease”. Journal of Clinical Hypertension 13, no. 11 (2011): 843–47.

Kalkhof, R. K. “Effects of Oral Contraceptive Agents and Sex Steroids on Carbohydrate Metabolism”. Annual Review of Medicine 23 (1972): 429–38.

Kemmeren, J. M., et al. “Effect of Second- and Third-Generation Oral Contraceptives on the Protein C System in the Absence or Presence of the Factor V Leiden Mutation: A Randomized Trial”. Blood 103, no. 3 (2004): 927–33.

Kemmeren, J. M., et al. “Effects of Second- and Third-Generation Oral Contraceptives and Their Respective Progestagens on the Coagulation System in the Absence or Presence of the Factor V Leiden Mutation”. Thrombosis and Haemostasis 87, no. 2 (2002): 199–205.

Kim, Sung-Woo, et al. “Long-Term Effects of Oral Contraceptives on the Prevalence of Diabetes in Post-menopausal Women: 2007–2012 KNHANES”. Endocrine 53, no. 3 (2016): 816–22.

Kjos, S. L., et al. “Contraception and the Risk of Type 2 Diabetes Mellitus in Latina Women with Prior Gestational Diabetes Mellitus”. JAMA 280, no. 6 (1998): 533.

Krauss, R. M., et al. “The Metabolic Impact of Oral Contraceptives”. American Journal of Obstetrics and Gynecology 167, no. 4, pt. 2 (1992): 1177–84.

Kuhl, H. “Hormonal Contraception and Substitution Therapy: The Importance of Progestogen for Cardiovascular Diseases”. [In German.] Geburtshilfe und Frauenheilkunde 52, no. 11 (1992): 653–62.